|Bid||0.00 x 1000|
|Ask||45.00 x 1000|
|Day's Range||43.57 - 46.00|
|52 Week Range||41.00 - 65.90|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||72.67|
BOSTON, November 18, 2021--PureTech announces that its Founded Entity, Gelesis, received a $30 million fully paid pre-order for Plenity® from Ro.
BOSTON, November 16, 2021--PureTech announces publication of Phase 1 results for LYT-100 in the journal Clinical Pharmacology in Drug Development and provides timing updates
BOSTON, November 15, 2021--PureTech announces that members of the management team will participate in fireside chats at two upcoming investor conferences.